Quadrature Capital’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-2,606
| Closed | -$672K | – | 1429 |
|
|
2025
Q2 | $672K | Buy |
+2,606
| New | +$622K | 0.01% | 495 |
|
|
2025
Q1 | – | Sell |
-2,326
| Closed | -$532K | – | 1414 |
|
|
2024
Q4 | $532K | Buy |
+2,326
| New | +$560K | 0.01% | 575 |
|
|
2024
Q3 | – | Sell |
-30,836
| Closed | -$5.9M | – | 1314 |
|
|
2024
Q2 | $5.9M | Buy |
+30,836
| New | +$6.26M | 0.1% | 167 |
|
|
2024
Q1 | – | Sell |
-56,379
| Closed | -$9.7M | – | 1449 |
|
|
2023
Q4 | $9.7M | Sell |
56,379
-140,824
| -71% | -$21.6M | 0.17% | 95 |
|
|
2023
Q3 | $29.2M | Buy |
197,203
+182,332
| +1,226% | +$33M | 0.6% | 40 |
|
|
2023
Q2 | $3.25M | Buy |
14,871
+4,894
| +49% | +$1.09M | 0.07% | 222 |
|
|
2023
Q1 | $2.18M | Buy |
9,977
+7,264
| +268% | +$1.58M | 0.06% | 268 |
|
|
2022
Q4 | $564K | Sell |
2,713
-3,509
| -56% | -$771K | 0.02% | 476 |
|
|
2022
Q3 | $1.36M | Buy |
6,222
+5,071
| +441% | +$1.15M | 0.04% | 322 |
|
|
2022
Q2 | $241K | Buy |
+1,151
| New | +$245K | 0.01% | 593 |
|
|
2022
Q1 | – | Sell |
-3,396
| Closed | -$885K | – | 942 |
|
|
2021
Q4 | $885K | Buy |
+3,396
| New | +$881K | 0.05% | 253 |
|
|
2021
Q2 | – | Sell |
-5,734
| Closed | -$1.11M | – | 1183 |
|
|
2021
Q1 | $1.11M | Buy |
+5,734
| New | +$1.15M | 0.05% | 292 |
|
|
2020
Q4 | – | Sell |
-5,594
| Closed | -$958K | – | 1031 |
|
|
2020
Q3 | $958K | Buy |
+5,594
| New | +$1.03M | 0.06% | 366 |
|
|
2020
Q2 | – | Sell |
-6,600
| Closed | -$970K | – | 786 |
|
|
2020
Q1 | $970K | Buy |
+6,600
| New | +$1.05M | 0.23% | 127 |
|
|
2018
Q4 | – | Sell |
-25,016
| Closed | -$2.89M | – | 637 |
|
|
2018
Q3 | $2.89M | Buy |
25,016
+15,776
| +171% | +$1.73M | 0.24% | 102 |
|
|
2018
Q2 | $957K | Sell |
9,240
-1,295
| -12% | -$131K | 0.09% | 233 |
|
|
2018
Q1 | $1.04M | Buy |
+10,535
| New | +$996K | 0.08% | 247 |
|
|
2017
Q2 | – | Sell |
-16,349
| Closed | -$1.18M | – | 744 |
|
|
2017
Q1 | $1.18M | Buy |
+16,349
| New | +$1.13M | 0.08% | 263 |
|
|
2016
Q3 | – | Sell |
-8,915
| Closed | -$564K | – | 706 |
|
|
2016
Q2 | $564K | Sell |
8,915
-39,994
| -82% | -$2.36M | 0.04% | 329 |
|
|
2016
Q1 | $2.83M | Buy |
+48,909
| New | +$2.77M | 0.39% | 69 |
|
|
2015
Q4 | – | Sell |
-16,016
| Closed | -$816K | – | 515 |
|
|
2015
Q3 | $816K | Buy |
+16,016
| New | +$862K | 0.27% | 112 |
|
Other funds holding RMD
Quadrature Capital's RMD Position: Q3 2025 in Review
Quadrature Capital sold out of ResMed (RMD) in Q3 2025, closing a stake of 2,606 shares — an estimated $672K sold.
Quadrature Capital first reported a position in RMD in Q3 2015 and held it in 21 quarters. The position peaked at $29.2M in Q3 2023. 950 funds tracked by Wall St. Rank hold RMD as of Q3 2025.
- Quadrature Capital reported no remaining ResMed position as of Q3 2025 after selling out during the quarter.
- Quadrature Capital sold 2,606 ResMed shares in Q3 2025, an estimated $672K.
- Quadrature Capital first reported a position in ResMed in Q3 2015 and held it in 21 quarters.
- Quadrature Capital's ResMed position peaked at $29.2M in Q3 2023.
- 950 funds tracked by Wall St. Rank held ResMed as of Q3 2025.
Based on Quadrature Capital's 13F filing for Q3 2025, filed 13 Nov 2025.